Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adequacy, app, Appendix, boost, bore, CAA, Candesartan, Centre, Cerebroprotein, circulation, citing, clearance, closedown, column, composition, consummation, COVID, crucial, Curve, deception, decision, defense, deleted, deletion, denied, deny, deviated, disseminated, divest, division, exert, eye, flagship, formular, gastrointestinal, GSP, Guideline, heightened, host, Hydroloysate, implied, incident, Interbank, invalid, irrespective, Justice, language, Lihua, Liu, Mendota, mental, MN, MOF, NMIB, Nomination, notified, notify, obstruction, obstructive, omitted, oversee, overseeing, pattern, penalty, promptly, protracted, quickly, quotation, recourse, reiterated, rejected, requisite, resolution, Revitalization, revolving, robust, sample, SAMR, sense, short, standing, storage, superimposing, systematic, Tao, threat, tradenamesFukexing, transmission, unforeseen, unrecoverable
Removed:
accuracy, AFGF, Auditing, biological, Buflomedil, CerebroproteinHydroloysate, Chairman, Cherry, commenced, communicating, confirming, controlling, Creek, employ, fax, float, flooded, frequently, Fukexing, halt, hit, Japan, Kingdom, offline, Rammasun, reevaluation, sensitivity, South, spent, super, surpassed, typhoon, water, winning
Filing tables
Filing exhibits
- 10-K Annual report
- 3.2 the First Amended and Restated Articles of Incorporation of the Company
- 3.3 the Second Amended and Restated Articles of Incorporation of the Company
- 10.13 Loan Settlement Agreement Between China Pharma Holdings, Inc. and MS. Zhilin Li
- 10.14 Technology Transfer Agreement Between Hainan Helpson Medical & Biotechnology Co., LTD and Tao Liu
- 10.15 Technology Transfer Agreement Between Hainan Helpson Medical & Biotechnology Co., LTD and Lihua Li
- 10.16 Office Lease for Second Floor of the Company's Principal Executive Office Dated June 5, 2023
- 10.17 Office Lease for Third Floor of the Company's Principal Executive Office Dated June 5, 2023
- 23.1 Consent of the Independent Accounting Firm.
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 97.1 Compensation Recovery Policy of the Company
- Download Excel data file
- View Excel data file
CPHI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement on Form S-3 (File No.: 333-276481) and Registration Statement on Form S-8 (File No.: 333-267989) of our report dated April 1, 2024 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries as of and for the years ended December 31, 2023 and 2022 appearing in this Annual Report on Form 10-K of China Pharma Holdings, Inc. for the year ended December 31, 2023.
/s/ B F Borgers CPA PC
B F Borgers CPA PC
Lakewood, CO
April 1, 2024